Live Breaking News & Updates on குறி ப்ரீடன்பாக் ஆபெந்ஹைமர் இணை

Stay updated with breaking news from குறி ப்ரீடன்பாக் ஆபெந்ஹைமர் இணை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Blood Therapeutics (GBT) Q2 2021 Earnings Call Transcript


Operator
Greetings, and welcome to Global Blood Therapeutics conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut. Please go ahead, sir.
Steven Immergut
Investor Relations
Thank you, and welcome to GBT s conference call to discuss the company s financial results for the second-quarter 2021 and to provide a business update. I m Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, will provide an update on our progress in the second quarter; Jeff Farrow, our chief financial officer, will review our financial results; David Johnson, or DJ, our chief commercial officer, will give an update on the Oxbryta launch; Dr. ....

United States , United Kingdom , City Of , David Johnson , Jason Gerberry , Kim Smith Whitley , Steven Immergut , Alethia Young , Courtney Roberts , Alethia Young Cantor Fitzgerald , Andrew Berens , Yanan Zhu , Elemer Piros , Paul Choi Goldman Sachs , Mark Breidenbach , Alan Anderson , Baral Cowen , Paul Choi , Jeff Farrow , Goldman Sachs , Kaiser Family Foundation , National Strategic Plan On Sickle Cell Disease , Sickle Cell Disease Association Of America , Mark Breidenbach Oppenheimer Co , National Academies Of Sciences , Company Analyst ,

Gamida Cell Ltd. (GMDA) Q4 2020 Earnings Call Transcript


Gamida Cell Ltd. (GMDA) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Gamida Cell Ltd. (NASDAQ: GMDA)
Q4 2020 Earnings Call
Ladies and gentlemen, thank you for standing by. Welcome to Gamida Cell s conference call for the full-year financial 2020 results. My name is Brandi, and I ll be your operator for today s call. Please be advised that this call is being recorded at Gamida Cell s request.
Now I would like to introduce your host for today s conference, Mr. Josh Hamermesh, chief business officer. Please go ahead.
Josh Hamermesh
Chief Business Officer
Thank you, Brandi, and good morning, everyone. Welcome to today s call, during which we will provide an update on the company and review our financial results for the full year of 2020. Earlier this morning, we issued a press release summarizing our financial results and progress across the company ....

United States , Kiryat Gat , Veronika Bachanova , Roy Buchanan , Ted Tenthoff Piper Sandler , Linda Stamler , Gil Blum , Josh Hamermesh , Jonathan Miller Evercore , Jason Butler , Gregory Renza , Rocio Manghani , Piper Sandler , Jonathan Miller , Mark Breidenbach , Michele Korfin , Tracey Lodie , Ted Tenthoff , Richard Childs , Shai Lankry , Julian Adams , Ronit Simantov , Israeli Innovation Authority , American Society Of Hematology Conference , National Institutes Of Health , Needham Company ,

Global Blood Therapeutics (GBT) Q4 2020 Earnings Call Transcript


Operator
Greetings, and welcome to Global Blood Therapeutics conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn this conference over to Mr. Steven Immergut.
Please go ahead, sir. You may begin.
Steven Immergut
Senior Vice President, Head of Corporate Communications, and Investor Relations
Thank you, and welcome to GBT s conference call to discuss the company s financial results for the fourth-quarter and full-year 2020 and to provide a business update. I m Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, who will provide a high-level update on our progress in the fourth quarter and over the full-year 2020; jeff Farrow, our chief financial officer, who will provide an overview of our financial results; and David Johnson, or DJ, our chief commercial officer, who will give an update on the Oxbryta launch. ....

New York , United States , David Johnson , Raymond James , Jason Gerberry , Kim Smith Whitley , Steven Immergut , Yatin Suneja Guggenheim , Alethia Young , Joe Hoven , Alethia Young Cantor Fitzgerald , Danielle Brill Raymond James , America Merrill Lynch , Danielle Brill , Gregory Renza , Matthew Harrison Morgan Stanley , Sadia Rahman , Paul Choi Goldman Sachs , Mark Breidenbach , Yatin Suneja , Matthew Harrison , Paul Choi , Jeff Farrow , Lyla Youssef Cowen , Morgan Stanley , Syros Pharmaceuticals ,